Stephen From's most recent trade in Vicarious Surgical Inc - Ordinary Shares - Class A was a trade of 297,600 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vicarious Surgical Inc (Class A) | Stephen From | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 297,600 | 297,600 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. | 05 Jan 2022 | 326 | 67,693 (1%) | 0% | 1.1 | 352 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 07 Dec 2021 | 273 | 68,019 (1%) | 0% | 1.3 | 355 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. | 02 Nov 2021 | 250 | 68,292 (1%) | 0% | 2.0 | 495 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.01 per share. | 04 Oct 2021 | 249 | 68,542 (1%) | 0% | 2.0 | 500 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 02 Sep 2021 | 253 | 68,791 (1%) | 0% | 1.8 | 458 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.40 per share. | 03 Aug 2021 | 261 | 69,044 (1%) | 0% | 2.4 | 626 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 02 Jul 2021 | 877 | 69,305 (1%) | 0% | 3.7 | 3,245 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.19 per share. | 04 Jun 2021 | 878 | 70,182 (1%) | 0% | 4.2 | 3,679 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share. | 04 May 2021 | 889 | 71,060 (1%) | 0% | 4.1 | 3,672 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.94 per share. | 08 Apr 2021 | 899 | 71,949 (1%) | 0% | 4.9 | 4,441 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.46 per share. | 03 Mar 2021 | 898 | 72,848 (1%) | 0% | 5.5 | 4,903 | Common Stock |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharma Inc | Stephen From | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.34 per share. | 01 Feb 2021 | 3,542 | 73,746 (1%) | 0% | 6.3 | 22,456 | Common Stock |